Trial Profile

Assessment of Pharmacokinetic Linearity and Relative Bioavailability of an Intranasal Diazepam Formulation Compared with Diazepam Rectal Gel in Healthy Adult Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Jul 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Diazepam (Primary) ; Diazepam (Primary)
Indications Seizures
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

25 Jun 2013 Results presented at the 30th International Epilepsy Congress.
25 Jun 2013 Results presented at the International Congress of the International League Against Epilepsy (ILAE) and International Bureau for Epilepsy (IBE), according to an Acorda Therapeutics media release.
23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com